3.連結財務諸表及び主な注記

(1)連結貸借対照表

 

 

 

 

 

 

 

 

 

 

 

(単位:千円)

 

 

 

 

 

 

 

 

 

 

前連結会計年度

(2025年9月30日)

当連結会計年度

(2026年9月30日)

資産の部

 

 

 

流動資産

 

 

 

 

現金及び預金

4,776,831

6,448,994

 

 

受取手形、売掛金及び契約資産

4,198,333

8,628,913

 

 

商品及び製品

20,842

670,229

 

 

原材料及び貯蔵品

2,214

5,790

 

 

前渡金

248,763

101,380

 

 

その他

54,129

175,861

 

 

貸倒引当金

△2,965

△892

 

 

流動資産合計

9,298,148

16,030,277

 

固定資産

 

 

 

 

有形固定資産

 

 

 

 

 

建物及び構築物

786,379

1,625,956

 

 

 

 

減価償却累計額

△563,018

△618,129

 

 

 

 

建物及び構築物(純額)

223,360

1,007,826

 

 

 

土地

139

744,199

 

 

 

その他

291,681

12,166,167

 

 

 

 

減価償却累計額

△241,971

△11,558,719

 

 

 

 

その他(純額)

49,709

607,448

 

 

 

有形固定資産合計

273,209

2,359,474

 

 

無形固定資産

 

 

 

 

 

のれん

-

1,234,839

 

 

 

顧客関連資産

-

1,062,398

 

 

 

その他

95,877

177,994

 

 

 

無形固定資産合計

95,877

2,475,232

 

 

投資その他の資産

 

 

 

 

 

投資有価証券

607,191

883,736

 

 

 

繰延税金資産

162,771

165,050

 

 

 

その他

432,203

817,196

 

 

 

投資その他の資産合計

1,202,166

1,865,983

 

 

固定資産合計

1,571,254

6,700,690

 

資産合計

10,869,403

22,730,967

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(単位:千円)

 

 

 

 

 

 

 

 

 

 

前連結会計年度

(2025年9月30日)

当連結会計年度

(2026年9月30日)

負債の部

 

 

 

流動負債

 

 

 

 

電子記録債務

-

1,619,131

 

 

買掛金

3,470,752

7,187,113

 

 

短期借入金

-

30,000

 

 

1年内返済予定の長期借入金

-

500,000

 

 

未払法人税等

36,538

275,252

 

 

契約負債

281,747

126,458

 

 

賞与引当金

103,099

255,478

 

 

役員賞与引当金

10,800

21,600

 

 

その他

263,477

743,398

 

 

流動負債合計

4,166,415

10,758,432

 

固定負債

 

 

 

 

長期借入金

-

4,125,000

 

 

退職給付に係る負債

300,473

647,277

 

 

役員退職慰労引当金

496,039

527,522

 

 

繰延税金負債

-

369,019

 

 

その他

87,114

224,543

 

 

固定負債合計

883,627

5,893,363

 

負債合計

5,050,042

16,651,796

純資産の部

 

 

 

株主資本

 

 

 

 

資本金

545,975

545,975

 

 

資本剰余金

505,551

518,403

 

 

利益剰余金

4,508,263

4,736,679

 

 

自己株式

△166

△166

 

 

株主資本合計

5,559,623

5,800,892

 

その他の包括利益累計額

 

 

 

 

その他有価証券評価差額金

75,224

83,190

 

 

その他の包括利益累計額合計

75,224

83,190

 

非支配株主持分

184,511

195,089

 

純資産合計

5,819,360

6,079,171

負債純資産合計

10,869,403

22,730,967

 

 

E34455 76810 株式会社レオクラン LEOCLAN Co.,Ltd. 通期第1号参考様式 [日本基準](連結) Japan GAAP true cte cte 2025-10-01 2026-09-30 FY 2026-09-30 2024-10-01 2025-09-30 2025-09-30 1 false false false 76810 2026-11-13 76810 2025-10-01 2026-09-30 76810 2025-10-01 2026-09-30 jppfs_cor:CapitalStockMember 76810 2025-10-01 2026-09-30 jppfs_cor:CapitalSurplusMember 76810 2025-10-01 2026-09-30 jppfs_cor:NonControllingInterestsMember 76810 2025-10-01 2026-09-30 jpcrp_cor:OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember 76810 2025-10-01 2026-09-30 jpcrp_cor:ReconcilingItemsMember 76810 2025-10-01 2026-09-30 jpcrp_cor:ReportableSegmentsMember 76810 2025-10-01 2026-09-30 jppfs_cor:RetainedEarningsMember 76810 2025-10-01 2026-09-30 jppfs_cor:ShareholdersEquityMember 76810 2025-10-01 2026-09-30 jpcrp_cor:TotalOfReportableSegmentsAndOthersMember 76810 2025-10-01 2026-09-30 jppfs_cor:TreasuryStockMember 76810 2025-10-01 2026-09-30 tse-acedjpfr-76810:MinimallyInvasiveMedicalDeviceSalesBusinessReportableSegmentMemberReportableSegmentMember 76810 2025-10-01 2026-09-30 tse-acedjpfr-76810:RemoteImageDiagnosisServiceBusinessReportableSegmentMember 76810 2025-10-01 2026-09-30 tse-acedjpfr-76810:RentalBusinessReportableSegmentMemberReportableSegmentMember 76810 2025-10-01 2026-09-30 tse-acedjpfr-76810:TotalMedicalSolutionBusinessReportableSegmentMember 76810 2025-10-01 2026-09-30 jppfs_cor:ValuationAndTranslationAdjustmentsMember 76810 2025-10-01 2026-09-30 jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember 76810 2026-09-30 76810 2026-09-30 jppfs_cor:CapitalStockMember 76810 2026-09-30 jppfs_cor:CapitalSurplusMember 76810 2026-09-30 jppfs_cor:NonControllingInterestsMember 76810 2026-09-30 jpcrp_cor:OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember 76810 2026-09-30 jpcrp_cor:ReconcilingItemsMember 76810 2026-09-30 jpcrp_cor:ReportableSegmentsMember 76810 2026-09-30 jppfs_cor:RetainedEarningsMember 76810 2026-09-30 jppfs_cor:ShareholdersEquityMember 76810 2026-09-30 jpcrp_cor:TotalOfReportableSegmentsAndOthersMember 76810 2026-09-30 jppfs_cor:TreasuryStockMember 76810 2026-09-30 tse-acedjpfr-76810:MinimallyInvasiveMedicalDeviceSalesBusinessReportableSegmentMemberReportableSegmentMember 76810 2026-09-30 tse-acedjpfr-76810:RemoteImageDiagnosisServiceBusinessReportableSegmentMember 76810 2026-09-30 tse-acedjpfr-76810:RentalBusinessReportableSegmentMemberReportableSegmentMember 76810 2026-09-30 tse-acedjpfr-76810:TotalMedicalSolutionBusinessReportableSegmentMember 76810 2026-09-30 jppfs_cor:ValuationAndTranslationAdjustmentsMember 76810 2026-09-30 jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember 76810 2024-10-01 2025-09-30 76810 2024-10-01 2025-09-30 jppfs_cor:CapitalStockMember 76810 2024-10-01 2025-09-30 jppfs_cor:CapitalSurplusMember 76810 2024-10-01 2025-09-30 jppfs_cor:NonControllingInterestsMember 76810 2024-10-01 2025-09-30 jpcrp_cor:OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember 76810 2024-10-01 2025-09-30 jpcrp_cor:ReconcilingItemsMember 76810 2024-10-01 2025-09-30 jpcrp_cor:ReportableSegmentsMember 76810 2024-10-01 2025-09-30 jppfs_cor:RetainedEarningsMember 76810 2024-10-01 2025-09-30 jppfs_cor:ShareholdersEquityMember 76810 2024-10-01 2025-09-30 jpcrp_cor:TotalOfReportableSegmentsAndOthersMember 76810 2024-10-01 2025-09-30 jppfs_cor:TreasuryStockMember 76810 2024-10-01 2025-09-30 tse-acedjpfr-76810:RemoteImageDiagnosisServiceBusinessReportableSegmentMember 76810 2024-10-01 2025-09-30 tse-acedjpfr-76810:TotalMedicalSolutionBusinessReportableSegmentMember 76810 2024-10-01 2025-09-30 jppfs_cor:ValuationAndTranslationAdjustmentsMember 76810 2024-10-01 2025-09-30 jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember 76810 2025-09-30 76810 2025-09-30 jppfs_cor:CapitalStockMember 76810 2025-09-30 jppfs_cor:CapitalSurplusMember 76810 2025-09-30 jppfs_cor:NonControllingInterestsMember 76810 2025-09-30 jpcrp_cor:OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember 76810 2025-09-30 jpcrp_cor:ReconcilingItemsMember 76810 2025-09-30 jpcrp_cor:ReportableSegmentsMember 76810 2025-09-30 jppfs_cor:RetainedEarningsMember 76810 2025-09-30 jppfs_cor:ShareholdersEquityMember 76810 2025-09-30 jpcrp_cor:TotalOfReportableSegmentsAndOthersMember 76810 2025-09-30 jppfs_cor:TreasuryStockMember 76810 2025-09-30 tse-acedjpfr-76810:RemoteImageDiagnosisServiceBusinessReportableSegmentMember 76810 2025-09-30 tse-acedjpfr-76810:TotalMedicalSolutionBusinessReportableSegmentMember 76810 2025-09-30 jppfs_cor:ValuationAndTranslationAdjustmentsMember 76810 2025-09-30 jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember 76810 2024-09-30 76810 2024-09-30 jppfs_cor:CapitalStockMember 76810 2024-09-30 jppfs_cor:CapitalSurplusMember 76810 2024-09-30 jppfs_cor:NonControllingInterestsMember 76810 2024-09-30 jppfs_cor:RetainedEarningsMember 76810 2024-09-30 jppfs_cor:ShareholdersEquityMember 76810 2024-09-30 jppfs_cor:TreasuryStockMember 76810 2024-09-30 jppfs_cor:ValuationAndTranslationAdjustmentsMember 76810 2024-09-30 jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember iso4217:JPY xbrli:pure